Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Luitpold Pharmaceuticals Inc.

Division of Daiichi Sankyo Co. Ltd.

Latest From Luitpold Pharmaceuticals Inc.

More US Positions Go As Daiichi Sankyo Refocuses

Attempts to maximize the current commercial portfolio and prepare for upcoming pipeline launches spell more job losses at the US arm of major Japanese pharma Daiichi Sankyo.

United States Commercial

Roxadustat To Overtake Epogen In Treating Anemia In CKD By 2021

The market for the treatment of anemia in chronic kidney disease will see Epogen eroded by biosimilars before the overall segment finally returns to growth following the launch of HIF-PHI inhibitor roxadustat, according to Datamonitor Healthcare's latest forecast.

Renal Market Intelligence

Code Cart Crisis: Anatomy Of An Emergency Drug Shortage

How FDA, health care providers, and Pfizer and other drug makers are responding to a shortage of emergency medicines from the fragile, overstressed US sterile injectables sector.

Manufacturing Quality

Generic Industry Consolidating But Still Mysterious

Nearly 2,000 ANDAs remain unclaimed as US FDA begins fee calculations for GDUFA II.

Generic Drugs FDA
See All

Company Information

  • Industry
  • Medical Devices
    • Biomaterials
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Daiichi Sankyo Co. Ltd.
  • Senior Management
  • Mary Jane Helenek, CEO
    Gopal Anyarambhatla, PhD, VP, R&D
    Mary M Lent, VP, Fin.
    Jacalyn Beltrani, VP, Commercial Ops., Iron Franchise
    Joel Steckler, VP, Commercial Ops., Multisource, An.Health, Osteo
  • Contact Info
  • Luitpold Pharmaceuticals Inc.
    Phone: (631) 924-4000
    One Luitpold Dr.
    P.O. Box 9001 Shirley, NY 11967